Cynthia C. Nast

Univ Of North Carolina Chapel Hill

$653,365

Attributed

$2,613,461

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $745.7K · FY2021–25

$1M$750K$500K$250K$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,613,461 · 1

By mechanism

R01$2,613,461 · 1

Top collaborators

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Adult”

Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
Susan M Landau · University Of California Berkeley$47,252,026
Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Evan Z Macosko · Broad Institute, Inc.$32,116,761

Research focus

AdultAncillary StudyAreaAffectBiological MarkersBiopsyCalcineurin InhibitorCardiovascular DiseasesCardiovascular SystemBiobankCategoriesCharacteristicsChronic Kidney FailureClinical DataClinical Research SiteCohortCollectionComorbidityComplexCostData CollectionCaringData HarmonizationDiabetes Mellitus

Grant awards (5)

The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes$598,715

R01 · FY2025 · DK

The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes$12,807

R01 · FY2025 · DK

The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes$605,141

R01 · FY2024 · DK

The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes$651,102

R01 · FY2022 · DK

The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes$745,696

R01 · FY2021 · DK